Immunosuppression in liver transplant recipients with renal impairment

被引：42
|
作者：
Duvoux, C. [1 ]
Pageaux, G. P. [2 ]
机构：
[1] Univ Paris Est, Hosp Henri Mondor, AP HP, Dept Hepatol & Gastroenterol,Liver Transplant Uni, Creteil, France
[2] Hosp St Eloi, Liver Transplant Unit, Montpellier, France
来源：
JOURNAL OF HEPATOLOGY | 2011年 / 54卷 / 05期
关键词：
Liver transplantation; Renal failure; Renal dysfunction; Immunosuppression; CNI toxicity; MYCOPHENOLATE-MOFETIL MONOTHERAPY; DOSE CALCINEURIN INHIBITOR; SIROLIMUS-BASED IMMUNOSUPPRESSION; GLOMERULAR-FILTRATION-RATE; TERM INDUCTION THERAPY; CHRONIC KIDNEY-DISEASE; HEPATITIS-C; RISK-FACTORS; REPLACEMENT THERAPY; DYSFUNCTION;
D O I：
10.1016/j.jhep.2010.12.001
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
[No abstract available]
引用
收藏
页码：1041 / 1054
页数：14
相关论文
共 50 条
  • [1] Initial immunosuppression in liver transplant recipients with impaired renal function
    Varo, E
    López, A
    Rivero, C
    [J]. TRANSPLANTATION PROCEEDINGS, 2005, 37 (09) : 3909 - 3912
  • [2] Improved Outcome after 'Bottom-Up' Immunosuppression in Liver Transplant Recipients with Preoperative Renal Impairment
    Schnitzbauer, Andreas A.
    Doenecke, Axel
    Sothmann, Johannes L.
    Loss, Martin
    Farkas, Stefan A.
    Hartl, Janine
    Tsui, Tung-Yu
    Baier, Lucia
    Kirchner, Gabriele
    Obed, Aiman
    Bein, Thomas
    Geissler, Edward K.
    Scherer, Marcus N.
    Schlitt, Hans J.
    [J]. EUROPEAN SURGICAL RESEARCH, 2010, 45 (3-4) : 356 - 367
  • [3] Weaning of immunosuppression in liver transplant recipients
    Mazariegos, GV
    Reyes, J
    Marino, IR
    Demetris, AJ
    Flynn, B
    Irish, W
    McMichael, J
    Fung, JJ
    Starzl, TE
    [J]. TRANSPLANTATION, 1997, 63 (02) : 243 - 249
  • [4] IMMUNOSUPPRESSION MINIMIZATION IN LIVER TRANSPLANT RECIPIENTS
    Mucha, Krzysztof
    Foroncewicz, Bartosz
    Lerut, Jan
    Moszczuk, Barbara
    Florczak, Michal
    Perkowska, Agnieszka
    Krata, Natalia
    Zagozdzon, Radoslaw
    Urbanowicz, Arkadiusz
    Kniola, Emilia
    Zieniewicz, Krzysztof
    Paczek, Leszek
    [J]. TRANSPLANT INTERNATIONAL, 2019, 32 : 386 - 387
  • [5] Immunosuppression for older liver transplant recipients
    De Simone, Paolo
    Battistella, Sara
    Lai, Quirino
    Ducci, Juri
    D'Arcangelo, Francesca
    Marchetti, Piero
    Russo, Francesco Paolo
    Burra, Patrizia
    [J]. TRANSPLANTATION REVIEWS, 2024, 38 (01)
  • [6] Belatacept Is Safe and Effective Bridging Immunosuppression in Liver Transplant Recipients with Renal Dysfunction
    LaMattina, John
    Jason, Mihaela
    Hanish, Steven
    Ottmann, Shane
    Klassen, David
    Potosky, Darryn
    Hutson, William
    Barth, Rolf
    [J]. AMERICAN JOURNAL OF TRANSPLANTATION, 2014, 14 : 95 - 95
  • [7] Impact of Everolimus-based Immunosuppression on Renal Function in Liver Transplant Recipients
    Nogueras Lopez, Flor
    Abellan Alfocea, Patricia
    Ortega Suazo, Eva Julissa
    Lopez Garrido, Maria Angeles
    Becerra Massare, Antonio
    Gila Medina, Ana Maria
    Redondo Cerezo, Eduardo
    Espinosa Aguilar, M. Dolores
    [J]. TRANSPLANTATION PROCEEDINGS, 2020, 52 (02) : 556 - 558
  • [8] Use of daclizumab as initial immunosuppression in liver transplant recipients with impaired renal function
    Emre, S
    Gondolesi, G
    Polat, K
    Ben-Haim, M
    Artis, T
    Fishbein, TM
    Sheiner, PA
    Kim-Schluger, L
    Schwartz, ME
    Miller, CM
    [J]. LIVER TRANSPLANTATION, 2001, 7 (03) : 220 - 225
  • [9] Immunosuppression strategies in elderly renal transplant recipients
    Camilleri, Brian
    Pararajasingam, Ravi
    Buttigieg, Jesmar
    Halawa, Ahmed
    [J]. TRANSPLANTATION REVIEWS, 2020, 34 (02)
  • [10] Immunosuppression and Metabolic Syndrome in Renal Transplant Recipients
    Lo, Agnes
    [J]. METABOLIC SYNDROME AND RELATED DISORDERS, 2004, 2 (04) : 263 - 273
12345